Travere Therapeutics, Inc. (TVTX)
51.64
+2.04
(+4.11%)
USD |
NASDAQ |
Nov 09, 16:00
50.91
-0.73
(-1.41%)
After-Hours: 17:42
Travere Therapeutics Gross Profit (Annual) : 419.65M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 419.65M |
| December 31, 2024 | 181.88M |
| December 31, 2023 | 95.26M |
| December 31, 2022 | 84.32M |
| December 31, 2021 | 194.09M |
| December 31, 2020 | 169.76M |
| December 31, 2019 | 149.70M |
| December 31, 2018 | 140.69M |
| December 31, 2017 | 133.53M |
| Date | Value |
|---|---|
| December 31, 2016 | 112.90M |
| December 31, 2015 | 84.32M |
| December 31, 2014 | 22.23M |
| December 31, 2013 | -0.216M |
| December 31, 2012 | -0.1249M |
| February 28, 2011 | 0.00 |
| February 28, 2010 | 0.00 |
| February 28, 2009 | 0.00 |
| February 29, 2008 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 10.27B |
| TG Therapeutics, Inc. | 515.57M |
| Viridian Therapeutics, Inc. | 69.69M |
| BioMarin Pharmaceutical, Inc. | 2.505B |
| Emergent BioSolutions, Inc. | 350.60M |